Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 9/20 | 0.60 |
| ▸ | TDO2 | P48775 | 2/20 | 0.42 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.35 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20308124 | 0.83 | EGFR (0.60) | EGFRTDO2PIK3CDPIK3CABAZ1A | |
| SCHEMBL2010019 | 0.79 | EGFR (0.60) | EGFRTDO2IMPDH2PIK3CDPIK3CA | |
| SCHEMBL8641138 | 0.78 | EGFR (0.64) | EGFRTDO2IMPDH2PIK3CDPIK3CA | |
| SCHEMBL1771613 | 0.75 | EGFR (0.60) | EGFRTDO2IMPDH2PIK3CDPIK3CA | |
| SCHEMBL277541 | 0.75 | EGFR (0.60) | EGFRTDO2IMPDH2PIK3CDPIK3CA | |
| SCHEMBL1403684 | 0.75 | EGFR (1.00) | EGFRTDO2IMPDH2 | |
| SCHEMBL559901 | 0.75 | EGFR (0.60) | EGFRTDO2IMPDH2PIK3CDPIK3CA | |
| SCHEMBL18618545 | 0.75 | EGFR (0.60) | EGFRTDO2IMPDH2PIK3CDPIK3CA | |
| SCHEMBL8207570 | 0.75 | EGFR (0.60) | EGFRTDO2IMPDH2PIK3CDPIK3CA | |
| SCHEMBL277540 | 0.75 | EGFR (0.60) | EGFRTDO2IMPDH2PIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| EP-3633380-A1 | METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 | Taiho Pharmaceutical Co., Ltd. (JP) | 2020-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | CCND1, CCND2, DRD1 | EGFR 1183/4885TDO2 122/4885IMPDH2 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.